Selective inhibition of the alternative complement pathway by sCR1[desLHR-a]protects the rabbit isolated heart from human complement-mediated damage
- 1 September 1996
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 34 (2-3) , 79-88
- https://doi.org/10.1016/0162-3109(96)00105-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- COMPLEMENT IN ORGAN TRANSPLANTATION CONTRIBUTIONS TO INFLAMMATION, INJURY, AND REJECTIONTransplantation, 1995
- Complement Activation and Inhibition in Myocardial Ischemia and Reperfusion InjuryAnnual Review of Pharmacology and Toxicology, 1994
- THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE REJECTION OF PORCINE XENOGRAFTSTransplantation, 1994
- Xenografting: probability, possibility, or pipe dream?The Lancet, 1993
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.The Journal of Experimental Medicine, 1988
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983
- Complement receptor is an inhibitor of the complement cascade.The Journal of Experimental Medicine, 1981
- Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery OcclusionJournal of Clinical Investigation, 1978
- THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATSThe Journal of Experimental Medicine, 1971